U.S. Hunts Indian-Origin Fugitive in $93 Million Medicare Fraud

U.S. authorities are hunting an Indian-origin man accused of orchestrating one of the largest Medicare fraud schemes in recent years, siphoning off millions through brazenly fabricated genetic test claims. Khadeer Khan Mohammed, now a fugitive, allegedly masterminded a plot that exploited physicians' identities and betrayed patient trust—all from an office in Texas.

The Anatomy of a Fraud

Mohammed’s company, American Premier, became a vehicle for deception. He or his associates submitted claims for laboratory genetic tests that were completely ineligible for reimbursement. The scale is staggering: in just ten days during 2023, Medicare paid out approximately $13 million for these suspicious tests.

How the Scheme Worked

The fraud relied on stealth and impersonation. Mohammed allegedly used physicians' personal identifying information without their knowledge or consent. These doctors had no treatment relationship with the patients whose tests were being billed. The genetic tests were never ordered by the physicians, and worse—they were never used in actual patient care.

“These tests were not ordered by the physicians and were not used in the care of the beneficiaries,” the Department of Health stated.

The Hunt Is On

With Mohammed believed to be in Hyderabad, the international manhunt underscores the borderless nature of modern white-collar crime. The Office of the Inspector General is working across agencies to locate him, but his current whereabouts remain unknown. For U.S. health officials, the case is a painful reminder of how easily trust can be monetized—and violated.